Clinical

Dataset Information

0

A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection


ABSTRACT: Primary Objective: -Evaluate the resection rate (R0/R1) in current practice for aflibercept in combination with irinotecan plus 5-fluorouracil (FOLFIRI) in patients treated for metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-containing regimen Secondary Objectives: * Evaluate overall survival, progression-free survival and relapse-free survival. * Evaluate conversion rates (initially unresectable disease which became resectable after chemotherapy, with R0/R1 resection). * Evaluate histological and radiological response rates. * Evaluate rate of postoperative complications. * Evaluate safety.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2399983 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2113482 | ecrin-mdr-crc
2022-10-05 | PXD031929 | Pride
2023-04-01 | GSE166310 | GEO
2024-01-02 | GSE223126 | GEO
| 2675770 | ecrin-mdr-crc
| 2367762 | ecrin-mdr-crc
2022-06-11 | GSE205852 | GEO
| 2524941 | ecrin-mdr-crc
| EGAS00001004371 | EGA
| 2292777 | ecrin-mdr-crc